Emily Schueddig

Emily Schueddig

Auto-generated profile, based on publicly available information

Emily Schueddig

University of Kansas Medical Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJ. K. Wiencke
J. K. Wiencke
AMAnnette M. Molinaro
Annette M. Molinaro
GWGayathri Warrier
Gayathri Warrier
TRTerri Rice
Terri Rice
JCJennifer Clarke
Jennifer Clarke
KKKarl T. Kelsey
Karl T. Kelsey
Assessing individual responses to glucocorticoid drug therapies that compromise immune status and affect survival outcomes in neuro-oncology is a great challenge. Here we introduce a blood-based neutrophil dexamethasone methylation index (NDMI) that provides a measure of the epigenetic response of subjects to dexamethasone. This marker outperforms conventional approaches based on leukocyte composition as a marker of glucocorticoid response. The NDMI is associated with low CD4 T cells and the accumulation of monocytic myeloid-derived suppressor cells and also serves as prognostic factor in glioma survival. In a non-glioma population, the NDMI increases with a history of prednisone use. Therefore, it may also be informative in other conditions where glucocorticoids are employed. We conclude that DNA methylation remodeling within the peripheral immune compartment is a rich source of clinically relevant markers of glucocorticoid response.

28 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
JWJohn Wiencke
John Wiencke
ENEmily Nissen
Emily Nissen
DKDevin Koestler
Devin Koestler
STStanley Tamaki
Stanley Tamaki
CTCourtney Tamaki
Courtney Tamaki
AMAnnette Molinaro
Annette Molinaro
Glioblastomas (GBM) are lethal central nervous system cancers associated with tumor and systemic immunosuppression. Heterogeneous monocyte myeloid-derived suppressor cells (M-MDSC) are implicated in the altered immune response in GBM, but M-MDSC ontogeny and definitive phenotypic markers are unknown. Using single-cell transcriptomics, we revealed heterogeneity in blood M-MDSC from GBM subjects and an enrichment in a transcriptional state reminiscent of neutrophil-like monocytes (NeuMo), a newly described pathway of monopoiesis in mice. Human NeuMo gene expression and Neu-like deconvolution fraction algorithms were created to quantitate the enrichment of this transcriptional state in GBM subjects. NeuMo populations were also observed in M-MDSCs from lung and head and neck cancer subjects. Dexamethasone (DEX) and prednisone exposures increased the usage of Neu-like states, which were inversely associated with tumor purity and survival in isocitrate dehydrogenase wildtype (IDH WT) gliomas. Anti-inflammatory ZC3HA12/Regnase-1 transcripts were highly correlated with NeuMo expression in tumors and in blood M-MDSC from GBM, lung, and head and neck cancer subjects. Additional novel transcripts of immune-modulating proteins were identified. Collectively, these findings provide a framework for understanding the heterogeneity of M-MDSCs in GBM as cells with different clonal histories and may reshape approaches to study and therapeutically target these cells.

28 August 2026
Verified
Other
Open access
KSKaty L. Swancutt
Katy L. Swancutt
RWRichard McKinnon Walsh
Richard McKinnon Walsh
SQSydney Quijano
Sydney Quijano
ESEmily Schueddig
Emily Schueddig
DKDevin C Koestler
Devin C Koestler
DWDanny R. Welch
Danny R. Welch
Top ten most abundant sequences aligning to mt-TR in each sample normalized to total mapped reads (in reads per million, RPM). Notable low overall abundance of sequences from pre-treated small RNA extracted from female mouse liver reflects technical challenges in the state of the art of RNA sequencing of tRNA and tRF (n = 3 samples per WT or MNX strain).

28 August 2026
Verified
Other
Open access
KSKaty L. Swancutt
Katy L. Swancutt
RWRichard McKinnon Walsh
Richard McKinnon Walsh
SQSydney Quijano
Sydney Quijano
ESEmily Schueddig
Emily Schueddig
DKDevin C Koestler
Devin C Koestler
DWDanny R. Welch
Danny R. Welch
AlphaFold3 predictive modeling of D-T Loop interactions of mt-TR

28 August 2026
Verified
Other
Open access
KSKaty L. Swancutt
Katy L. Swancutt
RWRichard McKinnon Walsh
Richard McKinnon Walsh
SQSydney Quijano
Sydney Quijano
ESEmily Schueddig
Emily Schueddig
DKDevin C Koestler
Devin C Koestler
DWDanny R. Welch
Danny R. Welch
AlphaFold3 predictive modeling of mt-TR suggests different stability and D–T-loop structures among strains. A, Sequences for each mt-TR (from left to right: C, H, and F) modeled without posttranscriptional modifications (PTM) and displayed predicted instability/low confidence. Predicted template modeling “pTM” scores range from 0.26 to 0.28 on a scale of 0–1. B, Three rows of images are displayed with increased zoom from top to bottom. To improve confidence predictions and better reflect known principles of tRNA folding (37), sequences for each strain were modeled according to reported PTM of human mt-TR (m1A, m2G, and Ψ; ref. 31). PTM inclusion increased predicted stability and confidence scoring compared with that of unmodified sequences (pTM range, 0.75–0.77 vs. 0.26–0.28). The D–T-loop interactions have the lowest scoring confidence, which aligns with the commonly observed transcript end (Table 1) of fragments between C: U53/G54; H: U55/G56; F: U54/G55 (highlighted in green in the bottom two rows of images). Nucleotides and structure of predicted interactions between the D–T-loop differ across strains: T-loop G54 is predicted to interact with the D-loop in C mt-TR; T-loop U57 is predicted to interact with the D-loop in H mt-TR; both U54/G55 are predicted to interact specifically with A17 of the T-loop in C mt-TR. Specific predictive bonding and distances between the center of nucleotides are listed in tRF patterns in liver tissue. pIDDT, predicted local distance difference test.

29 September 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
IWIan Weidling
Ian Weidling
ESEmily Schueddig
Emily Schueddig
XWXiaowan Wang
Xiaowan Wang
LNLesya Novikova
Lesya Novikova
BMBlaise W. Menta
Blaise W. Menta
RSRussell H. Swerdlow
Russell H. Swerdlow
Background: In Alzheimer's disease (AD), tau protein aggregates to form neurofibrillary tangles (NFTs). The cellular changes favoring AD brain NFT formation remain incompletely understood. AD brains also display mitochondrial defects, including reduced mitochondrial DNA (mtDNA) copy number. Objective: We considered whether mtDNA depletion alters tau homeostasis. Methods: We assessed tau mRNA using short-read mRNA sequencing and PCR, and tau protein using immunochemistry, in SH-SY5Y cells with chronic mtDNA depletion (ρ0). Results: mtDNA depletion increased tau expression and resulted in alternatively spliced isoforms, elevated 4R and exon 4a-containing MAPT transcripts, and consistently detectable big tau protein. ρ0 cells also displayed an elevated MAPT exon 13 3’Untranslated Region (UTR): Coding DNA sequence (CDS) ratio. Phosphorylation at amino acid positions 217 and 181 decreased. Conclusions: Mitochondrial dysfunction affects tau expression, splicing, and 3’UTR retention while increasing tau protein levels and modifying its phosphorylation. These studies hold AD relevance as they provide evidence for a relationship between two AD-associated phenomena, defective mitochondrial function and altered MAPT regulation.